218 related articles for article (PubMed ID: 24511377)
21. Oestrogen treatment enhances the sensitivity of hormone-resistant breast cancer cells to doxorubicin.
Scherbakov AM; Lobanova YS; Andreeva OE; Shatskaya VA; Krasil'nikov MA
Biosci Rep; 2011 Apr; 31(2):137-43. PubMed ID: 20662767
[TBL] [Abstract][Full Text] [Related]
22. Loss-of-function PCSK9 mutants evade the unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained.
Lebeau P; Platko K; Al-Hashimi AA; Byun JH; Lhoták Š; Holzapfel N; Gyulay G; Igdoura SA; Cool DR; Trigatti B; Seidah NG; Austin RC
J Biol Chem; 2018 May; 293(19):7329-7343. PubMed ID: 29593095
[TBL] [Abstract][Full Text] [Related]
23. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.
Pyrko P; Schönthal AH; Hofman FM; Chen TC; Lee AS
Cancer Res; 2007 Oct; 67(20):9809-16. PubMed ID: 17942911
[TBL] [Abstract][Full Text] [Related]
24. Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78.
Tsai HY; Yang YF; Wu AT; Yang CJ; Liu YP; Jan YH; Lee CH; Hsiao YW; Yeh CT; Shen CN; Lu PJ; Huang MS; Hsiao M
Oncogene; 2013 Oct; 32(41):4921-31. PubMed ID: 23318453
[TBL] [Abstract][Full Text] [Related]
25. IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments.
Grkovic S; O'Reilly VC; Han S; Hong M; Baxter RC; Firth SM
Oncogene; 2013 May; 32(19):2412-20. PubMed ID: 22751133
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy Controls Metastasis Through Stimulatory Effects on GRP78 and Its Transcription Factor CREB3L1.
Raiter A; Lipovetsky J; Hyman L; Mugami S; Ben-Zur T; Yerushalmi R
Front Oncol; 2020; 10():1500. PubMed ID: 33042795
[TBL] [Abstract][Full Text] [Related]
27. Taxol-induced unfolded protein response activation in breast cancer cells exposed to hypoxia: ATF4 activation regulates autophagy and inhibits apoptosis.
Notte A; Rebucci M; Fransolet M; Roegiers E; Genin M; Tellier C; Watillon K; Fattaccioli A; Arnould T; Michiels C
Int J Biochem Cell Biol; 2015 May; 62():1-14. PubMed ID: 25724736
[TBL] [Abstract][Full Text] [Related]
28. GRP78 regulates sensitivity of human colorectal cancer cells to DNA targeting agents.
Mhaidat NM; Alzoubi KH; Khabour OF; Banihani MN; Al-Balas QA; Swaidan S
Cytotechnology; 2016 May; 68(3):459-67. PubMed ID: 25399254
[TBL] [Abstract][Full Text] [Related]
29. Oestrogen- and anti-oestrogen-regulated genes in human breast cancer.
Rochefort H
Ciba Found Symp; 1995; 191():254-65; discussion 265-8. PubMed ID: 8582202
[TBL] [Abstract][Full Text] [Related]
30. IGFBP-3 sensitizes antiestrogen-resistant breast cancer cells through interaction with GRP78.
Li C; Harada A; Oh Y
Cancer Lett; 2012 Dec; 325(2):200-6. PubMed ID: 22801219
[TBL] [Abstract][Full Text] [Related]
31. Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients.
Bartkowiak K; Effenberger KE; Harder S; Andreas A; Buck F; Peter-Katalinic J; Pantel K; Brandt BH
J Proteome Res; 2010 Jun; 9(6):3158-68. PubMed ID: 20423148
[TBL] [Abstract][Full Text] [Related]
32. Characterizing Cell Stress and GRP78 in Glioma to Enhance Tumor Treatment.
Liu K; Tsung K; Attenello FJ
Front Oncol; 2020; 10():608911. PubMed ID: 33363039
[TBL] [Abstract][Full Text] [Related]
33. The COOH-Terminal Proline-Rich Region of GRP78 Is a Key Regulator of Its Cell Surface Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells.
Tseng CC; Zhang P; Lee AS
Neoplasia; 2019 Aug; 21(8):837-848. PubMed ID: 31306849
[TBL] [Abstract][Full Text] [Related]
34. Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance.
Ye R; Jung DY; Jun JY; Li J; Luo S; Ko HJ; Kim JK; Lee AS
Diabetes; 2010 Jan; 59(1):6-16. PubMed ID: 19808896
[TBL] [Abstract][Full Text] [Related]
35. Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer.
Nicholson RI; Hutcheson IR; Hiscox SE; Knowlden JM; Giles M; Barrow D; Gee JM
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S29-36. PubMed ID: 16113097
[TBL] [Abstract][Full Text] [Related]
36. GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy.
Firczuk M; Gabrysiak M; Barankiewicz J; Domagala A; Nowis D; Kujawa M; Jankowska-Steifer E; Wachowska M; Glodkowska-Mrowka E; Korsak B; Winiarska M; Golab J
Cell Death Dis; 2013 Jul; 4(7):e741. PubMed ID: 23887632
[TBL] [Abstract][Full Text] [Related]
37. AAV delivery of GRP78/BiP promotes adaptation of human RPE cell to ER stress.
Ghaderi S; Ahmadian S; Soheili ZS; Ahmadieh H; Samiei S; Kheitan S; Pirmardan ER
J Cell Biochem; 2018 Feb; 119(2):1355-1367. PubMed ID: 28782832
[TBL] [Abstract][Full Text] [Related]
38. Role of GRP78 in promoting therapeutic-resistant breast cancer.
Cook KL; Clarke R
Future Med Chem; 2015 Aug; 7(12):1529-34. PubMed ID: 26302335
[TBL] [Abstract][Full Text] [Related]
39. Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells.
Larsen SS; Heiberg I; Lykkesfeldt AE
Br J Cancer; 2001 Mar; 84(5):686-90. PubMed ID: 11237391
[TBL] [Abstract][Full Text] [Related]
40. The cytoprotective protein MANF promotes neuronal survival independently from its role as a GRP78 cofactor.
Eesmaa A; Yu LY; Göös H; Nõges K; Kovaleva V; Hellman M; Zimmermann R; Jung M; Permi P; Varjosalo M; Lindholm P; Saarma M
J Biol Chem; 2021; 296():100295. PubMed ID: 33460650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
